Literature DB >> 18345321

Indication for treatment and long-term outcome of focal nodular hyperplasia.

Glenn K Bonney1, Dhanwant Gomez, Ahmed Al-Mukhtar, Giles J Toogood, J Peter A Lodge, Raj Prasad.   

Abstract

INTRODUCTION: Unlike malignant liver tumours, the indications for hepatic resection for benign disease are not well defined. This is particularly true for focal nodular hyperplasia (FNH). Here we summarize a single-centre experience of the diagnosis and management of FNH.
MATERIALS AND METHODS: Using a prospectively collected database, a retrospective analysis of consecutive patients who were managed at our centre for FNH between January 1997 and December 2006 was performed.
RESULTS: The cohort was divided into two groups of patients: those who were managed surgically (n=15) and those managed conservatively (n=37). There was no correlation between tumour size and number of lesions with oral contraceptive use (p=0.07 and 0.90, respectively) and pregnancy (p=0.45 and 0.60, respectively). However, tumour size (p=0.006) and number of lesions (p=0.02) were associated with the occurrence of pain in these patients. Pain was the commonest symptom of patients (13/15) who were managed surgically. All patients underwent radiological imaging before diagnosis. The sensitivities of ultrasound, CT scanning and MRI scanning in characterizing these lesions were 30%, 70% and 87%, respectively. There were no postoperative deaths and three postoperative complications that were successfully managed non-operatively. With a median follow-up of 24 months in the surgically treated group, one patient has developed recurrent symptoms of pain. CONCLUSION. In this series, there was no mortality directly due to the surgical procedure and a modest morbidity, justifying surgical resections in selected patients.

Entities:  

Keywords:  benign liver tumours; focal nodular hyperplasia; hepatic resection

Year:  2007        PMID: 18345321      PMCID: PMC2225515          DOI: 10.1080/13651820701504173

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  14 in total

1.  Oral contraceptive use and focal nodular hyperplasia of the liver.

Authors:  D Mathieu; H Kobeiter; P Maison; A Rahmouni; D Cherqui; E S Zafrani; D Dhumeaux
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

Review 2.  The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia.

Authors:  S H Saul; D S Titelbaum; T S Gansler; M Varello; D R Burke; B F Atkinson; E F Rosato
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

3.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

4.  Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms.

Authors:  B N Nguyen; J F Fléjou; B Terris; J Belghiti; C Degott
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

5.  Focal nodular hyperplasia of the liver: results of treatment and options in management.

Authors:  J A Pain; A E Gimson; R Williams; E R Howard
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

6.  Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

Authors:  A Luciani; H Kobeiter; P Maison; D Cherqui; E-S Zafrani; D Dhumeaux; D Mathieu
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.

Authors:  P Kerlin; G L Davis; D B McGill; L H Weiland; M A Adson; P F Sheedy
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

8.  Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study.

Authors:  Jean-François Gigot; David Glineur; Juan Santiago Azagra; Martine Goergen; Marc Ceuterick; Mario Morino; José Etienne; Jacques Marescaux; Didier Mutter; Ludo van Krunckelsven; Bernard Descottes; Dominique Valleix; François Lachachi; Claude Bertrand; Baudouin Mansvelt; Guy Hubens; Jean-Pierre Saey; Romain Schockmel
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

9.  Nodular hyperplasia surrounding fibrolamellar carcinoma: a zone of arterialized liver parenchyma.

Authors:  R Saxena; S Humphreys; R Williams; B Portmann
Journal:  Histopathology       Date:  1994-09       Impact factor: 5.087

10.  Association of adenoma and focal nodular hyperplasia: experience of a single French academic center.

Authors:  Christophe Laurent; Hervé Trillaud; Sébastien Lepreux; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Comp Hepatol       Date:  2003-04-23
View more
  12 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

2.  Spontaneous regression of focal nodular hyperplasia: a pathological report.

Authors:  H Laumonier; F Leblanc; C Balabaud; P Bioulac-Sage
Journal:  BMJ Case Rep       Date:  2010-09-29

Review 3.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

Review 4.  Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection.

Authors:  Alex P Navarro; Dhanwant Gomez; Christopher M Lamb; Adam Brooks; Iain C Cameron
Journal:  HPB (Oxford)       Date:  2013-10-15       Impact factor: 3.647

5.  Research on focal nodular hyperplasia with MSCT and postprocessing.

Authors:  Yuan-Jian Liu; Wei-Jun Fan; Zhi-Dong Yuan; Peng-Cheng Liu; Chun-Rong Wang; Wei-Qiang Yan; Su-Mei Wang; Jun-Hui Chen; Zheng Liu
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

6.  Understanding the natural history of focal nodular hyperplasia in the liver with MRI.

Authors:  Jaydeep A Halankar; Tae Kyoung Kim; Hyun-Jung Jang; Korosh Khalili; Haider A Masoom
Journal:  Indian J Radiol Imaging       Date:  2012-04

7.  An unusual case of left hepatectomy for Focal Nodular Hyperplasia (FNH) linked to the use of Anabolic Androgenic Steroids (AASs).

Authors:  Angela Romano; Michele Grassia; Giuseppe Esposito; Marianna Petrillo; Modestino Pezzella; Francesco Maria Romano; Francesco Esposito; Francesco Torelli; Natale Di Martino
Journal:  Int J Surg Case Rep       Date:  2016-11-03

8.  Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre.

Authors:  Mirelle E E Bröker; Anne J Klompenhouwer; Marcia P Gaspersz; Annick M E Alleleyn; Roy S Dwarkasing; Indra C Pieters; Robert A de Man; Jan N M IJzermans
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

9.  Laparoscopic partial hepatectomy of focal nodular hyperplasia.

Authors:  Mayu Sakata; Tsuyoshi Syoji; Raisuke Nishiyama; Masami Taniguchi; Masanori Yamazaki; Yukihiro Higashi; Kunihito Suzuki; Takahumi Kawamura; Hajime Yonekawa; Hirotoshi Maruo
Journal:  Case Rep Gastroenterol       Date:  2012-11-08

10.  The value of liver resection for focal nodular hyperplasia: resection yes or no?

Authors:  Hans Michael Hau; Georgi Atanasov; Hans-Michael Tautenhahn; Rudolf Ascherl; Georg Wiltberger; Markus Bo Schoenberg; Mehmet Haluk Morgül; Dirk Uhlmann; Michael Moche; Jochen Fuchs; Moritz Schmelzle; Michael Bartels
Journal:  Eur J Med Res       Date:  2015-10-22       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.